phase ib/ii trial of 177lu-girentuximab with cabozantinib and nivolumab in clear cell rcc
Published 1 month ago • 45 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
1:20
promising results of cabozantinib plus nivolumab in non-clear cell rcc
-
2:40
updates on the cabopre phase ii trial in patients with metastatic renal cell carcinoma
-
3:29
emerging roles of nivolumab and cabozantinib for renal cell carcinoma
-
1:29
phase i/ii study of nivolumab and axitinib for advanced rcc
-
1:40
phase iii meteor trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
-
1:58
phase ii trial of nivolumab plus ipilimumab in advanced bladder cancer of variant histologies
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
2:17
zirco: 89zr-dfo-girentuximab for pet/ct imaging of clear cell renal cell carcinoma
-
9:09
nivolumab with alternatively scheduled ipilimumab in first-line treatment of advanced rcc
-
2:25
dr. motzer on a phase ii trial of nivolumab for mrcc
-
5:44
hcrn-gu16-260: nivolumab and salvage nivolumab-ipilimumab in patients with advanced rcc
-
1:32
dr. voss on phase i/ii trial data of medi0680/durvalumab versus nivolumab in mrcc
-
1:26
phase i trial of copanlisib nivolumab in patients with richter’s transformation or transformed fl
-
4:05
long-term rcc data with nivolumab
-
11:42
nivolumab in renal cell carcinoma
-
5:42
meteor trial: cabozantinib vs everolimus in advanced renal cell carcinoma
-
4:55
phase ib/ii trial of combination pd-1 therapy against kidney cancer
-
5:59
prosper rcc study of perioperative nivolumab for renal cell carcinoma - future trial
-
2:27
changing the standard of care in previously treated metastatic renal cell carcinoma